HOME >> MEDICINE >> NEWS
Bacterium present in eyes with 'wet' age-related macular degeneration

p>Most of the new medications either marketed or being developed to treat wet AMD, such as Macugen (EyeTech Pharmaceuticals) and Lucentis (Genetech) block VEGF.

The study comes at a time of great interest in inflammatory mediators of AMD. Over the past seven months, a flurry of high-impact papers have shown, in aggregate, that nearly 50 percent of AMD can be explained by variations in a gene called Complement Factor H (CFH). This gene makes a protein that regulates the immune and inflammatory responses of the body.

"Our hypothesis is that C. pneumoniae may be the key link between CFH and AMD," Kalayoglu said. "That is, patients with CFH variations may be particularly susceptible to the damaging effects of chronic infection, and an infectious organism like C. pneumoniae may be particularly effective in accelerating inflammation and driving progression of AMD in these patients."

Kalayoglu and colleagues are currently collaborating with CFH researchers to study this hypothesis. "It may be possible to stop or reverse progression of AMD by identifying susceptible patients by diagnostic testing, and then treating these susceptible patients. Although C. pneumoniae is a bacterium that might respond to some antibiotics, much more work needs to be done before considering antibiotic therapy for AMD," he said.

"This is an important study suggesting that infection with C. pneumoniae may be a critical link between a genetic predisposition to AMD and actual progression to disease," said Gerald I. Byrne, Ph.D., professor and chairman of the Department of Molecular Sciences University of Tennessee Health Sciences Center. "This is yet another example of how an infection may unexpectedly contribute to a chronic disease. Certainly the association of C. pneumoniae with heart disease sets the stage for this pathogen's involvement in other chronic conditions. This work is, in some ways, reminiscent of studies done more than 15 years ago on infections and
'"/>

Contact: Mary E. Leach
mary_leach@meei.harvard.edu
617-573-4170
Harvard Medical School
7-Nov-2005


Page: 1 2 3

Related medicine news :

1. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
2. Cedars-Sinai researchers present new endocrine findings at 2 international conferences
3. Revlimid data presented at ASCO stands to change the way physicians treat multiple myeloma
4. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
5. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
6. Ulcerative colitis remission rates from long-term safety study of LIALDA presented at DDW
7. NYP/Weill Cornell Urologists present at 2007 AUA Conference
8. Data on new vaccine for prostate cancer to be presented
9. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
10. Epidemiology of TB: Updates from CDC studies to be presented at ATS 2007
11. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... 20, 2017 , ... “Knowledge is God’s Lighthouse”: a moving and colorful ... Lighthouse” is the creation of published author, Gene Gaapf, a retired truck driver, and ... “I have been writing since high school and have many different titles,” Gaapf mentions ...
(Date:1/19/2017)... Angeles (PRWEB) , ... January 19, 2017 , ... Next ... Act will be repealed by Congressional political games that circumvent health needs of over ... Stand Rally” capture the human anxieties and needs government public servants were suppose to ...
(Date:1/19/2017)... ... January 19, 2017 , ... WhoHaha , a digital media company ... Heart Association (AHA) to produce a three-part video series that uses humor to highlight ... of the launch of AHA’s Healthy For Good™ movement, which is designed to inspire ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... the American Board of Dermatology and fellowship trained Mohs and cosmetic surgeon. After ... of Health, Dr. Li completed his internship in internal medicine at the Emory ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... ... Health, is now offering treatments for patients with sleep apnea and TMJ disorders. ... for dental and physical health. Dr. Rassouli provides personalized care to reduce the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 Shire ... that the U.S. Food and Drug Administration (FDA) has ... New Drug Application (NDA) for SHP465, a long-acting, triple-bead, ... a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The ... around June 20, 2017, the designated Prescription Drug User ...
(Date:1/19/2017)... , January 19, 2017 ... Therapeutic Option to Address Motor Symptoms and Motor ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... Stocchi , European Neurological Review,2016;11(Suppl. 2): 2-15, ...
(Date:1/19/2017)... 2017 , , Marks E-QURE , ... distribution agreement, following similar agreements in Israel ... is $2 5 billion global market ... (OTCQB: EQUR), a leader in medical devices for the treatment of advanced wound ... Médicos S.A.S. (TeckMedica) in Colombia for the Company,s patented ...
Breaking Medicine Technology:
Cached News: